2024-11-11T16:27:41-06:00 2023-12-31 330783700 PDM LLP 3460 TORRANCE BLVD STE 200 TORRANCE CA 90503 990 2023-01-01 731663091 COMPLETE CARE COMMUNITY HEALTH CENTER I COMP 3107306362 3000 S ROBERTSON BLVD STE 280 LOS ANGELES CA 90034 DMITRIY VELIN CFO 3107306362 2024-11-07 1 0 ANTHONY P BOZANIC CPA P01314417 3105404118 2023 2024-10-15 13:58:12Z DMITRIY VELIN 3000 S ROBERTSON BLVD STE 280 LOS ANGELES CA 90034 45067228 0 X HTTPS://CCCHCLINIC.COM X 2002 CA THE ORGANIZATION IS DEVOTED TO SERVING THE MEDICAL NEEDS OF THE UNDERPRIVILEGED OF CALIFORNIA. 11 11 263 11 0 0 3118232 2014220 31903169 42260909 -106950 792099 0 0 34914451 45067228 0 0 0 0 17058805 20091334 0 0 0 16782180 21362504 33840985 41453838 1073466 3613390 45059203 45085699 27800436 24213542 17258767 20872157 THE ORGANIZATION'S MISSION IS TO ELIMINATE DISPARITIES IN HEALTH CARE ACCESS AND OUTCOMES BY PROVIDING SUPERIOR QUALITY HEALTH AND HUMAN SERVICES THROUGH AN INTEGRATED WORLD-CLASS DELIVERY SYSTEM FOR UNDERSERVED COMMUNITIES IN CALIFORNIA. 0 0 36275085 42260909 THE ORGANIZATION IS DEVOTED TO SERVING THE MEDICAL NEEDS OF THE UNDERPRIVILEGED AND LOW INCOME INDIVIDUALS AND FAMILIES IN THE COUNTY OF LOS ANGELES AND THE SURROUNDING COMMUNITY WITH OUTSTANDING, TIMELY AND COMPASSIONATE PATIENT CARE. IN 2023, THE ORGANIZATION PROVIDED LOW COST OR FREE MEDICAL CARE TO 114,135 QUALIFIED PATIENT ENCOUNTERS. 36275085 1 1 0 0 0 0 0 0 0 0 1 1 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 60 0 1 263 1 0 0 0 0 0 0 0 0 0 0 X 11 11 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 CA X X DMITRIY VELIN 3107306362 3000 S ROBERTSON BLVD STE 280 LOS ANGELES CA 90034 DINA LENCHITSKY CHAIRMAN 2.00 X X 0 0 0 JOYCE REESE SECRETARY 2.00 X X 0 0 0 SONIA HENRIQUEZ DIRECTOR 2.00 X 0 0 0 VICTORIA MAKEROVA DIRECTOR 2.00 X 0 0 0 ERNESTO HARO DIRECTOR 2.00 X 0 0 0 WENDY NAVARETE TENORIO DIRECTOR 2.00 X 0 0 0 INESSA MIRETSKY DIRECTOR 2.00 X 0 0 0 ANTHONY WILLIS DIRECTOR 2.00 X 0 0 0 MARIELLA MANBRENO DIRECTOR 2.00 X 0 0 0 MARISOL JIMENEZ DIRECTOR 2.00 X 0 0 0 CLARENCE THOMAS CHAIRMAN (ELECTED NOVEMBER 2.00 X X 0 0 0 YURY AKOPYAN CEO 40.00 X 398196 0 24750 DMITRIY VELIN CPA CFO 32.00 X 233027 0 25762 SERGEY M TIRAYAN COO 40.00 X 256500 0 28733 RAMACHANDRAN SRINIVASAN MD CMO 40.00 X 520000 0 24750 ZHANNA FELDSHER MD MEDICAL DOCTOR 40.00 X 316765 0 35605 GHASSAN AL-JAZAYRLY MD MEDICAL DOCTOR 40.00 X 511154 0 42999 LALITHA ANANTH RHEUMATOLOGY 40.00 X 276328 0 20725 KEVIN AKOPIAN CLINIC ADMINISTRATOR 40.00 X 258832 0 28075 HARUT MADATOVIAN MEDICAL DOCTOR 40.00 X 303872 0 28287 3074674 0 259686 9 0 1 0 JOSHUA LEVY 5128 BLUEBELL AVE VALLEY VILLAGE CA 91607 MEDICAL CONSULTANT 250000 OPTIMAL WEST EAST MEDICINE 3831 HUGHES AVE 601 CULVER CITY CA 90232 MEDICAL CONSULTANT 245000 DR DAVID LAVIAN PO BOX TARZANA CA 91356 MEDICAL CONSULTANT 207194 ALKADRY CORP PO BOX HAWTHORNE CA 90251 MEDICAL CONSULTANT 149760 CENTURY WOMEN MEDICAL GROUP INC 8679 W PICO BLVD LOS ANGELES CA 90035 MEDICAL CONSULTANT 108000 5 2014220 2014220 PATIENT SERVICES 624110 23661822 23661822 PHARMACEUTICALS 624110 18599087 18599087 42260909 792099 792099 45067228 42260909 0 792099 1511718 1322862 188856 14809475 12552759 2256716 2560952 2174202 386750 1209189 1027811 181378 3082817 2871228 211589 276540 276540 1110599 944009 166590 597468 507848 89620 2085383 1772576 312807 206508 175532 30976 16249 13812 2437 1232390 1047532 184858 501233 426048 75185 PHARMACEUTICALS COS 9720751 9720751 MEDICAL SUPPLIES AND PH 792791 792791 SETTLEMENT COSTS 700000 700000 OUTSIDE SERVICES 626420 532457 93963 413355 116327 297028 41453838 36275085 5178753 0 12173704 9243761 1724186 1435753 440383 20734 407034 56586 142678 9591122 2064765 4334297 7526357 15940701 15732355 820990 1058211 9988005 9099167 45059203 45085699 3238756 3009690 275843 667119 24285837 20536733 27800436 24213542 X 17258767 20872157 17258767 20872157 45059203 45085699 3613390 0 X 0 1 X 1 1 1 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 817397 817397 2628875 95595 2533280 5007064 1696267 3310797 833431 68200 765231 304355 204703 99652 7526357 INVESTMENTS - POOLED SEPERATE ACCOUNTS 15732355 F 15732355 SECURITY DEPOSITS 311035 OPERATING LEASE RIGHT-OF-USE ASSETS 8788132 9099167 ACCRUED MEDI-CAL RECONCILIATION 5369251 OPERATING LEASE LIABILITIES 9141810 OTHER LIABILITIES 5325672 ACCRUED RESERVE CONTINGENT LIABILITY 700000 20536733 X 45067228 0 45067228 0 45067228 41453838 0 41453838 0 41453838 PART X, LINE 2: THE ORGANIZATION RECOGNIZES THE IMPACT OF TAX POSITIONS IN THE FINANCIAL STATEMENTS IF THAT POSITION IS MORE LIKELY THAN NOT OF BEING SUSTAINED ON AUDIT, BASED ON THE TECHNICAL MERITS OF THE POSITION. TO DATE, THE ORGANIZATION HAS NOT RECORDED ANY UNCERTAIN TAX POSITIONS. THE ORGANIZATION RECOGNIZES POTENTIAL ACCRUED INTEREST AND PENALTIES RELATED TO UNCERTAIN TAX POSITIONS IN INCOME TAX EXPENSE. DURING THE YEAR ENDED DECEMBER 31, 2023, THE ORGANIZATION DID NOT RECOGNIZE ANY AMOUNT IN POTENTIAL INTEREST AND PENALTIES ASSOCIATED WITH UNCERTAIN TAX POSITIONS. X 0 0 0 0 0 0 0 0 0 GHASSAN AL-JAZAYRLY MD MEDICAL DOCTOR 511154 0 0 0 0 0 24750 0 18249 0 554153 0 0 0 RAMACHANDRAN SRINIVASAN MD CMO 520000 0 0 0 0 0 24750 0 0 0 544750 0 0 0 YURY AKOPYAN CEO 398196 0 0 0 0 0 24750 0 0 0 422946 0 0 0 ZHANNA FELDSHER MD MEDICAL DOCTOR 316765 0 0 0 0 0 23658 0 11947 0 352370 0 0 0 HARUT MADATOVIAN MEDICAL DOCTOR 303872 0 0 0 0 0 22744 0 5543 0 332159 0 0 0 LALITHA ANANTH RHEUMATOLOGY 276328 0 0 0 0 0 20725 0 0 0 297053 0 0 0 KEVIN AKOPIAN CLINIC ADMINISTRATOR 258832 0 0 0 0 0 19340 0 8735 0 286907 0 0 0 SERGEY M TIRAYAN COO 256500 0 0 0 0 0 19158 0 9575 0 285233 0 0 0 DMITRIY VELIN CPA CFO 233027 0 0 0 0 0 17407 0 8355 0 258789 0 0 0 EVERGREEN RX INC RELATED PARTY X 440383 440383 0 1 1 440383 YURY AKOPYAN CEO THE BOARD 1 SCH L, PART IV, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS: THE BOARD OF DIRECTORS ("BOARD") OF THE ORGANIZATION APPROVED CONTRACTED PHARMACY SERVICES WITH EVERGREEN RX, INC. DBA MEDICO PHARMACY ("EVERGREEN") ON OCTOBER 18, 2015 AND SUBSEQUENTLY, THE CONTRACT TOOK EFFECT ON DECEMBER 1, 2015. DURING THE MEETING WITH THE BOARD, IT WAS DISCLOSED THAT CHIEF EXECUTIVE OFFICER ("CEO") OF THE ORGANIZATION HAS AN OWNERSHIP INTEREST IN EVERGREEN. THE CONFLICT OF INTEREST DISCLOSURE STATEMENT SUBMITTED BY YURY AKPOYAN, CEO EARLIER IN 2015 WAS REVIEWED BY THE BOARD. THE BOARD RESOLVED THAT THERE WERE NO MORE BENEFICIAL ALTERNATIVES FOR THE ORGANIZATION TO THE PROPOSED 340B PHARMACY CONTRACT. THE BOARD THEN DETERMINED BY A MAJORITY VOTE THAT THE PROPOSED 340B PHARMACY CONTRACT BETWEEN THE ORGANIZATION AND EVERGREEN IS IN THE ORGANIZATION'S BEST INTEREST AND IS FAIR AND REASONABLE TO THE ORGANIZATION. THE FULL DISCLOSURE WAS ALSO MADE TO THE ORGANIZATION'S PROJECT OFFICER AT HRSA. SINCE THEN THE CONTRACT WAS REAPPROVED BY THE ORGANIZATION'S BOARD ON OCTOBER 22, 2017, AND, MOST RECENTLY ON MAY 23, 2022. THE ANNUAL CONFLICT OF INTEREST DISCLOSURE STATEMENTS WERE SUBMITTED TO THE BOARD EVERY YEAR, DISCLOSING THE FACT THAT YURY AKOPYAN, CEO HAS AN OWNERSHIP INTEREST IN EVERGREEN. THE CONTRACT TOOK EFFECT ON MAY 23, 2022. THE CONTRACT IS VALID THROUGH THE EXTENDED CONTRACT DATE OF MAY 22, 2025.IN ADDITION, THE AGREEMENT WAS REVIEWED AND APPROVED BY HRSA DURING THEIR SITE VISIT DURING JUNE 2022. EVERGREEN DISPENSES 340B DISCOUNTED DRUGS TO THE ORGANIZATION'S PATIENTS. FOR THE YEAR ENDED DECEMBER 31, 2023, THE ORGANIZATION RECOGNIZED $18,599,087 OF REVENUE FROM EVERGREEN. THIS AMOUNT REPRESENTS 100% OF PHARMACEUTICALS COST OF SALES PLUS 50% OF EVERGREEN'S GROSS PROFITS ON PHARMACEUTICALS SOLD. BEGINNING IN JANUARY 2024, THE BOARD OF DIRECTORS OF THE ORGANIZATION NEGOTIATED WITH EVERGREEN AND AGREED TO AN UPDATED FORMULA WHEREBY THE ORGANIZATION WILL RECOGNIZE 70% OF PHARMACEUTICAL GROSS SALES. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 IS REVIEWED BY THE CFO AND THE BOARD MEMBERS BEFORE IT IS FILED. FORM 990, PART VI, SECTION B, LINE 12C ANNUALLY, DURING THE BOARD MEETING, THE CEO, CFO AND THE CHAIR OF THE BOARD GO THROUGH WITH ALL THE BOARD MEMBERS OVER THE COMPANY CONFLICT OF INTEREST POLICY AND SEE IF ANY ISSUES ARISE. FORM 990, PART VI, SECTION B, LINE 15A THE ORGANIZATION'S BOARD OF DIRECTORS ANNUALLY APPROVES THE CEO SALARY. THE CEO ANNUALLY DETERMINES THE COMPENSATION OF MEMBERS OF MANAGEMENT. FORM 990, PART VI, SECTION C, LINE 19 THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICIES AND THE AUDITED FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE GENERAL PUBLIC UPON REQUEST.